1. Home
  2. NICM vs BNR Comparison

NICM vs BNR Comparison

Compare NICM & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nicola Mining Inc. American Depositary Shares

NICM

Nicola Mining Inc. American Depositary Shares

N/A

Current Price

$5.85

Market Cap

120.4M

Sector

N/A

ML Signal

N/A

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.36

Market Cap

94.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICM
BNR
Founded
N/A
2014
Country
Canada
China
Employees
25
667
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
94.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NICM
BNR
Price
$5.85
$9.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0K
15.0K
Earning Date
N/A
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.77
$5.31
52 Week High
$6.48
$41.72

Technical Indicators

Market Signals
Indicator
NICM
BNR
Relative Strength Index (RSI) 47.97 42.06
Support Level $5.92 $8.34
Resistance Level $6.38 $10.00
Average True Range (ATR) 0.16 0.85
MACD -0.03 -0.01
Stochastic Oscillator 35.34 6.41

Price Performance

Historical Comparison
NICM
BNR

About NICM Nicola Mining Inc. American Depositary Shares

Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: